Wednesday, August 27, 2014
Inquirer Daily News

Ex-Synthes executives to be sentenced in late November

Ex-Synthes executives to be sentenced in late November for their role in an illegal clinical trial of bone cement used in spinal surgery.

Ex-Synthes executives to be sentenced in late November

Four former executives of the medical-device manufacturer Synthes Inc., each of whom pleaded guilty to a misdemeanor charge stemming from an illegal clinical trial of a bone cement, will be sentenced in late November, according to court records.

Three people died on the operating table during spinal operations involving the cement, which had not been approved by the FDA for that purpose.

Thomas B. Higgins and Michael D. Huggins are scheduled for sentencing Nov. 21, while Richard E. Bohner and John J. Walsh are scheduled for sentencing Nov. 22.

Swiss-based Synthes, which has facilities in Chester County, and its former wholly owned subsidiary, Norian, paid $23 million in fines in 2010 to settle the corporate charges brought by the U.S. Attorney’s Office in Philadelphia. In April, Synthes agreed to be bought by Johnson & Johnson for $21.3 billion.

Update: Adam Hoffinger, the attorney for Thomas Higgins, declined to comment on the case.

The June 5 Inquirer story on this topic can be found here.

David Sell
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Business Videos:
Also on Philly.com:
Stay Connected